Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Zero based budgeting tips for families of 5 or more focus on scalable categories, collaborative planning, and routine check-ins to maintain control.
27,424 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Dexe surged about 50% in a single session despite a broad market downturn, trading near the mid-20s as traders evalua...
Duquesne Family Office revealed positions in three AI infrastructure semiconductor firms, signaling a thematic bet on...
The MORT ETF offers a double-digit yield, but its payout hinges on the health of its mortgage REIT holdings. This art...
Stocks drift lower as market chatter hints OpenAI may delay its IPO, sending the Nasdaq Composite and tech names into...
Bitcoin’s price finally entered a defined buy zone this week, signaling a potential shift in sentiment as traders wei...
A fresh market screen identifies five high-yield dividend stocks trading under $10, presenting a potential income lif...
A u.s. official says billion could be freed from frozen Iranian assets this week as Oman discusses potential Hormuz t...
OpenAI is quietly pitching its products to U.S. military and national security clients, a move that could reshape fun...
The Antinozzi Group rejoined Compass in Houston after a period with REMAX, led by Joe Antinozzi and Kristin Weaver. I...
The FBI director disclosed a late Strategy stock purchase, prompting questions about STOCK Act timing and potential c...
Meta's exploration of renting idle GPU capacity as a cloud resource has sparked a heated, split view on Wall Street. ...